CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis

Abstract

Many studies have reported the relationship between CXCL12 G801A polymorphism and cancer risk, with conflicting results. In this study, we tried to clarify the possibility that this polymorphism may increase cancer risk by conducting an updated meta-analysis. PubMed and EMbase were searched for case-control studies regarding the association of the gene polymorphism and cancer risk. Data were extracted and odds ratios (ORs) with 95% confidence intervals (95% CIs) were used to assess the strength of the association. Heterogeneity among articles and publication bias was also assessed. Significantly increased risk for cancer was found (A vs. G: OR=1.26, 95% CI=1.13–1.40, P<0.01; AA+AG vs. GG: OR=1.33, 95% CI=1.16–1.52, P<0.01). In subgroup analysis, statistically elevated cancer risk was found in both Asian and Caucasian populations (for Asian, AA+AG vs. GG: OR=1.74, 95% CI=1.22–2.47, P<0.01; for Caucasian, AA+AG vs. GG: OR=1.24, 95% CI=1.09–1.42, P<0.01). Our result indicated that CXCL12 G801A polymorphism is a risk factor for cancer. To validate the finding, further large-size case-control studies are warranted.

Keywords

CXCL12 / polymorphism / cancer risk / meta-analysis

References

[1] AndrewAS, NelsonHH, KelseyKT, et al. . Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis, 2006, 27(5): 1030-1037 PMID: 16311243

[2] PharoahPD, DunningAM, PonderBA, et al. . Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer, 2004, 4(11): 850-860 PMID: 15516958

[3] DomanskaUM, KruizingaRC, NagengastWB, et al. . A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur J Cancer, 2013, 499(1): 219-230

[4] ShirozuM, NakanoT, InazawaJ, et al. . Structure and chromosomal localization of the human stromal cell-derived factor-1 (SDF1) gene. Genomics, 1995, 28(3): 495-500 PMID: 7490086

[5] MullerA, HomeyB, SotoH, et al. . Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410(6824): 50-56 PMID: 11242036

[6] YunHJ, JoDY. Production of stromal cell-derived factor-1 (SDF-1) and expression of CXCR4 in human bone marrow endothelial cells. J Korean Med Sci, 2003, 18(5): 679-685 PMCID: 3055109 PMID: 14555820

[7] NagasawaT, HirotaS, TachibanaK, et al. . Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 1996, 382(6592): 635-638 PMID: 8757135

[8] BleulCC, FarzanM, ChoeH, et al. . The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 1996, 382(6594): 829-833 PMID: 8752280

[9] SorianoA, MartinezC, GarciaF, et al. . Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3’A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type1 infection and its progression. J Infect Dis, 2002, 186(7): 922-931 PMID: 12232832

[10] HirataH, HinodaY, KikunoN, et al. . CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res, 2007, 13(17): 5056-5062 PMID: 17785557

[11] UchidaD, BegumN-M, TomizukaY, et al. . Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Lab Invest, 2004, 84(12): 1538-1546 PMID: 15492752

[12] RazmkhahM, DoroudchiM, GhayumiSM, et al. . Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer, 2005, 49(3): 311-315 PMID: 15955592

[13] RazmkhahM, TaleiAR, DoroudchiM, et al. . Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett, 2005, 225(2): 261-266 PMID: 15978329

[14] de OliveiraCE, CavassinGG, Perim-AdeL, et al. . Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients. J Clin Lab Anal, 2007, 21(1): 49-54 PMID: 17245764

[15] de Oliveira-CavassinGG, De LuccaFL, Delgado-AndréN, et al. . Molecular investigation of the stromal cell derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. Blood Cells Mol Dis, 2004, 33(1): 90-93 PMID: 15223017

[16] DerSimonianR, LairdN. Meta-analysis in clinical trials. Control Clin Trials, 1986, 7(3): 177-188 PMID: 3802833

[17] MantelN, HaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 1959, 22(4): 719-748 PMID: 13655060

[18] MoosaviSR, KhorramdelazadH, AminM, et al. . The SDF-1 3’A genetic variation is correlated with elevated intratumor tissue and circulating concentration of CXCL12 in glial tumors: a study on Iranian anaplastic astrocytoma and glioblastoma multiforme patients. J Mol Neurosci, 2013, 50(2): 298-304 PMID: 23335032

[19] TengYH, LiuTH, TsengHC, et al. . Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer. Head Neck, 2009, 31(10): 1282-1288 PMID: 19373784

[20] ChangCC, ChenSC, HsiehYH, et al. . Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological developpment of hepatocellular carcinoma. Clin Chem Lab Med, 2009, 47(4): 412-418 PMID: 19327121

[21] TheodoropoulosGE, PanoussopoulosGS, MichalopoulosNV, et al. . Analysis of the stromal cell-derived factor 1-3’A gene polymorphism in pancreatic cancer. Mol Med Rep, 2010, 3(4): 693-698 PMID: 21472301

[22] MazurG, GeburaK, GieryngA, et al. . The CXCL12-3’A allele plays a favourable role in patients with multiple myeloma. Cytokine, 2013, 64(1): 422-426 PMID: 23711392

[23] GawronAJ, FoughtAJ, LissowskaJ, et al. . Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population. Scand J Gastroenterol, 2011, 46(3): 333-340 PMCID: 3035749 PMID: 21091093

[24] MaleySN, SchwartzSM, JohnsonLG, et al. . Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study. Int J Immunogenet, 2009, 36(6): 367-375 PMCID: 2784202 PMID: 19788587

[25] EnjuanesA, BenaventeY, BoschF, et al. . Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer Res, 2008, 68(24): 10178-10186 PMID: 19074885

[26] DommangeF, CartronG, EspanelC, et al. . CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia. FASEB J, 2006, 20(11): 1913-1915 PMID: 16818471

[27] KwonEM, SalinasCA, KolbS, et al. . Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 2011, 20(5): 923-933 PMCID: 3140053 PMID: 21430300

[28] CaiC, WangLH, DongQ, et al. . Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma. Tissue Antigens, 2013, 82(3): 165-170 PMID: 24032722

[29] LeeYL, KuoWH, LinCW, et al. . Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer. Lung Cancer, 2011, 73(2): 147-152 PMID: 21292343

[30] LinGT, TsengHF, YangCH, et al. . Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS, 2009, 13(2): 165-172 PMID: 19196101

[31] ShiMD, ChenJH, SungHT, et al. . CXCL12-G801A polymorphism modulates risk of colorectal cancer in Taiwan. Arch Med Sci, 2013, 9(6): 999-1005 PMCID: 3902706 PMID: 24482642

[32] TeeYT, YangSF, WangPH, et al. . G801A polymorphism of human stromal cell-derived factor1 gene raises no susceptibility to neoplastic lesions of uterine cervix. Int J Gynecol Cancer, 2012, 22(8): 1297-1302 PMID: 22954782

[33] LiuW, ZhuE, WangR, et al. . CXCL12 G801A polymorphism is associated with an increased risk of benign salivary gland tumors in the Chinese population. Med Oncol, 2012, 29(2): 677-681 PMID: 21298365

[34] VairaktarisE, VylliotisA, SpyridonodouS, et al. . A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer. Anticancer Res, 2008, 28(1A): 271-275 PMID: 18383856

[35] Hidalgo-PascualM, GalanJJ, Chaves-CondeM, et al. . Analysis of CXCL12 3’UTR G>A polymorphism in colorectal cancer. Oncol Rep, 2007, 18(6): 1583-1587 PMID: 17982648

[36] IsmanFK, KucukgerginC, DasdemirS, et al. . Association between SDF1-3’A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases. Mol Biol Rep, 2012, 39(12): 11073-11079 PMID: 23053994

[37] Ben-NasrM, ReguayaZ, BerraiesL, et al. . Association of stromal cell-derived factor-1-3’A polymorphism to higher mobilization of hematopoietic stem cells CD34+ in Tunisian population. Transplant Proc, 2011, 43(2): 635-638 PMID: 21440782

[38] BracciPM, SkibolaCF, CondeL, et al. . Chemokine polymorphisms and lymphoma: a pooled analysis. Leuk Lymphoma, 2010, 51(3): 497-506 PMCID: 3443685 PMID: 20038229

[39] de OliveiraKB, GuembarovskiRL, OdaJM, et al. . CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients. Cytokine, 2011, 55(2): 260-265 PMID: 21592819

[40] de OliveiraKB, OdaJM, VoltarelliJC, et al. . CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin’s lymphoma, and non-Hodgkin’s lymphoma. J Clin Lab Anal, 2009, 23(6): 387-393 PMID: 19927352

[41] KruszynaL, LianeriM, RydzaniczM, et al. . SDF1-3’ a gene polymorphism is associated with laryngeal cancer. Pathol Oncol Res, 2010, 16(2): 223-227 PMID: 19834823

[42] KruszynaL, LianeriM, RubisB, et al. . CXCL12-3’ G801A polymorphism is not a risk factor for breast cancer. DNA Cell Biol, 2010, 29(8): 423-427 PMID: 20406099

[43] Vázquez-LavistaLG, LimaG, GabilondoF, et al. . Genetic association of monocyte chemoattractant protein-1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology, 2009, 74(2): 414-418 PMID: 19646633

[44] CacinaC, Bulgurcuoglu-KuranS, IyibozkurtAC, et al. . Genetic variants of SDF-1 and CXCR4 genes in endometrial carcinoma. Mol Biol Rep, 2012, 39(2): 1225-1229 PMID: 21607621

[45] DimbergJ, HuganderA, LöfgrenS, et al. . Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med, 2007, 19(1): 11-15 PMID: 17143542

[46] RazmkhahM, GhaderiA. SDF-1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers. Indian J Gastroenterol, 2013, 32(1): 28-31 PMID: 23242967

[47] ZafiropoulosA, CrikasN, PassamA, et al. . Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet, 2004, 41(5): e59 PMCID: 1735773 PMID: 15121787

[48] KucukgerginC, IsmanFK, DasdemirS, et al. . The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer. Gene, 2012, 511(1): 7-11 PMID: 22982413

[49] de Lourdes-PerimA, GuembarovskiRL, OdaJM, et al. . CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL). Mol Biol Rep, 2013, 40(7): 4591-4596 PMID: 23653000

[50] KhademiB, RazmkhahM, ErfaniN, et al. . SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathol Oncol Res, 2008, 14(1): 45-50 PMID: 18386165

[51] KontogianniP, ZambirinisCP, TheodoropoulosG, et al. . The impact of the stromal cell-derived factor-1-3’A and E-selectin S128R polymorphisms on breast cancer. Mol Biol Rep, 2013, 40(1): 43-50 PMID: 23129313

[52] LiarmakopoulosE, TheodoropoulosG, VaiopoulouA, et al. . Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk. Mol Med Rep, 2013, 7(3): 887-892 PMID: 23258739

[53] WinklerC, ModiW, SmithMW, et al. . Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science, 1998, 279(5349): 389-393 PMID: 9430590

[54] CaruzA, SamsomM, AlonsoJM, et al. . Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett, 1998, 426(2): 271-278 PMID: 9599023

[55] McGrathKE, KoniskiAD, MaltbyKM, et al. . Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol, 1999, 213(2): 442-456 PMID: 10479460

[56] BurgerJA, KippsTJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood, 2006, 107(5): 1761-1767 PMID: 16269611

[57] MaXY, JinY, SunHM, et al. . CXCL12 G801A polymorphism contributes to cancer susceptibility: a meta-analysis. Cell Mol Biol(Noisy-le-grand), 2012, 58: OL1702-OL1708

[58] GongH, TanM, WangY, et al. . CXCL12 G801A polymorphism and cancer risk: evidence from-17 case-control studies. Gene, 2012, 509(2): 228-231 PMID: 22939870